Clinical studies recruiting near Gaithersburg

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · CBH Health · Bristol-Myers Squibb · NCT06929273 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Kaiser Permanente-Gaithersburg Medical Center · NRG Oncology · NCT05174169 Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
Phase 2 · CenExel - Gaithersburg · Rapport Therapeutics Inc. · NCT07046494 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Kaiser Permanente-Gaithersburg Medical Center · NRG Oncology · NCT06748222 An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Ma
Phase 2 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07288320 Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Maj
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06966401 Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Phase 3 · Reviva site · Reviva Pharmaceuticals · NCT05184335 Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · Kaiser Permanente-Gaithersburg Medical Center · NRG Oncology · NCT05080673 A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
Phase 3 · Cenexel CBH (CBH Health) · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT06894212 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · Kaiser Permanente-Gaithersburg Medical Center · SWOG Cancer Research Network · NCT06616584 Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Sympt
Phase 3 · CBH Health, LLC dba CenExel · Minerva Neurosciences · NCT07565428 A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Phase 3 · Local Institution - 1636 · Bristol-Myers Squibb · NCT06937229 NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07114874 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Kaiser Permanente-Gaithersburg Medical Center · National Cancer Institute (NCI) · NCT04267848 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Kaiser Permanente-Gaithersburg Medical Center · SWOG Cancer Research Network · NCT03851445 A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
Phase 2 · CBH Health · Eli Lilly and Company · NCT07286175 A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Al
Phase 3 · CBH Health · Bristol-Myers Squibb · NCT07011732 ALTO-100 in Bipolar Disorder With Depression (BD-D)
Phase 2 · Site 6062 · Alto Neuroscience · NCT06656416 Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A L
Phase 2 · Kaiser Permanente-Gaithersburg Medical Center · SWOG Cancer Research Network · NCT05642572 NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06963034 Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After
Phase 3 · Kaiser Permanente-Gaithersburg Medical Center · Alliance for Clinical Trials in Oncology · NCT05812807 DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit
NA · QIAGEN Gaithersburg, Inc · NCT06645236 52-week Open Label Safety-Tolerability Study
Phase 3 · CenExel Gaithersburg · LB Pharmaceuticals Inc. · NCT07369154 Integrating Free-choice Marketplace, dieTitian coacHing, cultuRally Tailored messagIng to improVE Blood Pressure
NA · Holy Cross Hospital · Johns Hopkins University · NCT07075588 Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung
Phase 2 · Kaiser Permanente-Gaithersburg Medical Center · SWOG Cancer Research Network · NCT06031688 A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2
Phase 3 · CBH Health · Bristol-Myers Squibb · NCT06951711 A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult P
Phase 2 · Cbh Health - Gaithersburg /ID# 272932 · AbbVie · NCT07145918 Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal
Phase 3 · Kaiser Permanente-Gaithersburg Medical Center · NRG Oncology · NCT05879926 A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
Phase 2 · Cenexel CBH · Kynexis B.V. · NCT07191483 Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Phase 2/Phase 3 · Mid-Atlantic Permanente Research Institute · Vertex Pharmaceuticals Incorporated · NCT05312879

Look up another city

Look up another condition